| Total |
| Combined Series (4:3:1:3:3)d |
68 |
69 |
73 |
73 |
73 |
74 |
75 |
79 |
81 |
81 |
61 |
64 |
68 |
68 |
67 |
68 |
69 |
75 |
77 |
77 |
70 |
71 |
75 |
75 |
75 |
75 |
76 |
81 |
83 |
83 |
| Combined series (4:3:1:3)e |
76 |
76 |
79 |
78 |
76 |
77 |
78 |
81 |
83 |
82 |
69 |
71 |
74 |
73 |
71 |
72 |
72 |
76 |
78 |
79 |
80 |
79 |
82 |
81 |
78 |
79 |
79 |
83 |
85 |
84 |
| Combined series (4:3:1)f |
78 |
78 |
81 |
80 |
78 |
79 |
79 |
82 |
84 |
83 |
72 |
72 |
76 |
75 |
72 |
73 |
73 |
77 |
79 |
80 |
81 |
80 |
83 |
82 |
79 |
80 |
80 |
84 |
86 |
85 |
| DTP (4 doses or more)g |
81 |
82 |
84 |
83 |
82 |
82 |
82 |
85 |
86 |
86 |
74 |
76 |
80 |
79 |
76 |
77 |
75 |
80 |
81 |
82 |
84 |
84 |
86 |
85 |
84 |
84 |
84 |
87 |
87 |
87 |
| Polio (3 doses or more)h |
91 |
91 |
91 |
90 |
90 |
89 |
90 |
92 |
92 |
92 |
88 |
89 |
90 |
87 |
87 |
87 |
88 |
89 |
90 |
90 |
92 |
92 |
92 |
91 |
90 |
90 |
91 |
93 |
92 |
92 |
| MMR (1 dose or more)i |
91 |
90 |
92 |
92 |
91 |
91 |
92 |
93 |
93 |
92 |
87 |
86 |
90 |
90 |
89 |
89 |
90 |
92 |
91 |
89 |
92 |
92 |
93 |
92 |
91 |
92 |
92 |
93 |
94 |
92 |
| Hib (3 doses or more)j |
91 |
93 |
93 |
94 |
93 |
93 |
93 |
94 |
94 |
94 |
87 |
90 |
91 |
91 |
90 |
90 |
90 |
91 |
92 |
92 |
93 |
94 |
95 |
95 |
95 |
94 |
94 |
95 |
94 |
95 |
| Hepatitis B (3 doses or more)k |
82 |
84 |
87 |
88 |
90 |
89 |
90 |
92 |
92 |
93 |
78 |
81 |
85 |
87 |
87 |
87 |
88 |
91 |
91 |
91 |
83 |
85 |
88 |
89 |
91 |
90 |
90 |
93 |
93 |
94 |
| Varicellal |
12 |
26 |
43 |
58 |
68 |
76 |
81 |
85 |
88 |
88 |
5 |
17 |
41 |
55 |
64 |
74 |
79 |
84 |
86 |
87 |
15 |
29 |
44 |
58 |
69 |
77 |
81 |
85 |
88 |
88 |
| 3 PCVm |
— |
— |
— |
— |
— |
— |
41 |
68 |
73 |
83 |
— |
— |
— |
— |
— |
— |
33 |
62 |
69 |
78 |
— |
— |
— |
— |
— |
— |
43 |
71 |
75 |
84 |
| White, non-Hispanic |
| Combined Series (4:3:1:3:3)d |
69 |
70 |
76 |
76 |
76 |
75 |
78 |
83 |
83 |
82 |
59 |
64 |
72 |
71 |
70 |
68 |
70 |
77 |
77 |
76 |
71 |
71 |
76 |
76 |
77 |
76 |
78 |
83 |
84 |
83 |
| Combined series (4:3:1:3)e |
79 |
79 |
82 |
81 |
79 |
79 |
80 |
84 |
85 |
84 |
68 |
72 |
77 |
76 |
73 |
71 |
72 |
79 |
78 |
78 |
80 |
80 |
83 |
82 |
80 |
80 |
81 |
85 |
86 |
85 |
| Combined series (4:3:1)f |
80 |
80 |
83 |
82 |
80 |
80 |
81 |
85 |
86 |
84 |
70 |
73 |
79 |
77 |
74 |
72 |
73 |
80 |
78 |
78 |
82 |
82 |
84 |
83 |
81 |
81 |
82 |
86 |
87 |
85 |
| DTP (4 doses or more)g |
83 |
84 |
87 |
86 |
84 |
84 |
84 |
88 |
88 |
87 |
72 |
76 |
82 |
81 |
78 |
75 |
75 |
82 |
81 |
81 |
85 |
85 |
88 |
86 |
85 |
85 |
86 |
88 |
89 |
88 |
| Polio (3 doses or more)h |
92 |
92 |
92 |
90 |
91 |
90 |
91 |
93 |
92 |
91 |
88 |
90 |
91 |
88 |
88 |
87 |
88 |
91 |
88 |
87 |
93 |
92 |
93 |
91 |
91 |
91 |
92 |
93 |
93 |
92 |
| MMR (1 dose or more)i |
91 |
91 |
93 |
92 |
92 |
92 |
93 |
93 |
94 |
91 |
85 |
84 |
90 |
90 |
88 |
87 |
90 |
90 |
90 |
87 |
93 |
93 |
94 |
93 |
92 |
92 |
93 |
94 |
94 |
92 |
| Hib (3 doses or more)j |
93 |
94 |
95 |
95 |
95 |
94 |
94 |
95 |
95 |
94 |
87 |
90 |
92 |
93 |
92 |
89 |
88 |
91 |
92 |
89 |
94 |
95 |
96 |
95 |
95 |
95 |
95 |
96 |
95 |
95 |
| Hepatitis B (3 doses or more)k |
82 |
85 |
88 |
89 |
91 |
90 |
91 |
93 |
93 |
93 |
76 |
80 |
87 |
88 |
88 |
86 |
86 |
91 |
92 |
90 |
83 |
85 |
88 |
89 |
92 |
90 |
92 |
94 |
93 |
94 |
| Varicellal |
15 |
28 |
42 |
56 |
66 |
75 |
79 |
84 |
87 |
86 |
6 |
17 |
38 |
51 |
58 |
67 |
75 |
80 |
84 |
82 |
16 |
29 |
43 |
57 |
68 |
76 |
80 |
85 |
87 |
87 |
| 3 PCVm |
— |
— |
— |
— |
— |
— |
44 |
71 |
75 |
83 |
— |
— |
— |
— |
— |
— |
31 |
59 |
66 |
76 |
— |
— |
— |
— |
— |
— |
46 |
73 |
77 |
84 |
| Black, non-Hispanic |
| Combined Series (4:3:1:3:3)d |
67 |
66 |
67 |
69 |
68 |
67 |
68 |
73 |
75 |
79 |
61 |
64 |
67 |
67 |
67 |
65 |
66 |
69 |
72 |
76 |
72 |
70 |
68 |
73 |
70 |
69 |
68 |
77 |
78 |
83 |
| Combined series (4:3:1:3)e |
74 |
73 |
73 |
74 |
71 |
71 |
71 |
75 |
76 |
81 |
68 |
71 |
72 |
72 |
69 |
69 |
68 |
70 |
74 |
77 |
79 |
77 |
74 |
77 |
72 |
74 |
72 |
79 |
80 |
84 |
| Combined series (4:3:1)f |
77 |
74 |
74 |
75 |
72 |
73 |
72 |
77 |
78 |
81 |
73 |
72 |
74 |
74 |
70 |
71 |
69 |
72 |
76 |
78 |
81 |
78 |
76 |
78 |
73 |
75 |
73 |
80 |
81 |
84 |
| DTP (4 doses or more)g |
79 |
77 |
77 |
79 |
76 |
76 |
76 |
80 |
80 |
84 |
74 |
76 |
77 |
78 |
75 |
74 |
74 |
75 |
78 |
80 |
83 |
80 |
79 |
83 |
78 |
78 |
77 |
84 |
83 |
88 |
| Polio (3 doses or more)h |
90 |
89 |
88 |
87 |
87 |
85 |
87 |
89 |
90 |
91 |
87 |
89 |
88 |
86 |
85 |
84 |
87 |
86 |
90 |
89 |
93 |
91 |
87 |
88 |
87 |
86 |
87 |
91 |
91 |
93 |
| MMR (1 dose or more)i |
90 |
89 |
89 |
90 |
88 |
89 |
90 |
92 |
91 |
92 |
88 |
87 |
89 |
90 |
88 |
88 |
90 |
91 |
90 |
91 |
91 |
91 |
90 |
91 |
87 |
90 |
90 |
93 |
91 |
93 |
| Hib (3 doses or more)j |
89 |
91 |
90 |
92 |
93 |
90 |
92 |
92 |
91 |
93 |
86 |
91 |
90 |
91 |
92 |
87 |
88 |
90 |
90 |
92 |
93 |
94 |
90 |
94 |
93 |
91 |
94 |
95 |
92 |
95 |
| Hepatitis B (3 doses or more)k |
82 |
82 |
84 |
87 |
89 |
85 |
88 |
92 |
91 |
93 |
78 |
82 |
86 |
86 |
89 |
85 |
89 |
92 |
89 |
93 |
85 |
84 |
83 |
90 |
90 |
85 |
88 |
92 |
92 |
94 |
| Varicellal |
9 |
21 |
42 |
58 |
67 |
75 |
83 |
85 |
86 |
91 |
— |
16 |
40 |
57 |
60 |
71 |
80 |
84 |
85 |
91 |
13 |
27 |
44 |
60 |
72 |
77 |
84 |
86 |
87 |
91 |
| 3 PCVm |
— |
— |
— |
— |
— |
— |
34 |
62 |
68 |
80 |
— |
— |
— |
— |
— |
— |
30 |
61 |
67 |
77 |
— |
— |
— |
— |
— |
— |
38 |
64 |
70 |
82 |
| Hispanicc |
| Combined Series (4:3:1:3:3)d |
64 |
66 |
69 |
70 |
69 |
74 |
73 |
77 |
80 |
79 |
62 |
62 |
65 |
68 |
66 |
70 |
72 |
77 |
79 |
78 |
64 |
70 |
73 |
73 |
70 |
76 |
73 |
78 |
82 |
79 |
| Combined series (4:3:1:3)e |
71 |
73 |
75 |
75 |
73 |
74 |
76 |
79 |
81 |
81 |
68 |
70 |
73 |
73 |
65 |
73 |
75 |
78 |
80 |
81 |
73 |
77 |
79 |
78 |
74 |
79 |
76 |
81 |
84 |
82 |
| Combined series (4:3:1)f |
74 |
75 |
77 |
77 |
75 |
79 |
77 |
79 |
82 |
82 |
71 |
71 |
76 |
76 |
73 |
76 |
76 |
79 |
80 |
81 |
75 |
77 |
80 |
80 |
75 |
80 |
77 |
81 |
84 |
83 |
| DTP (4 doses or more)g |
77 |
78 |
81 |
80 |
79 |
83 |
79 |
82 |
84 |
84 |
74 |
75 |
79 |
78 |
76 |
79 |
78 |
81 |
83 |
83 |
78 |
81 |
83 |
82 |
80 |
83 |
80 |
84 |
86 |
85 |
| Polio (3 doses or more)h |
89 |
90 |
89 |
89 |
88 |
91 |
90 |
90 |
91 |
92 |
88 |
88 |
90 |
89 |
88 |
90 |
89 |
89 |
90 |
92 |
90 |
90 |
90 |
90 |
87 |
91 |
91 |
92 |
92 |
92 |
| MMR (1 dose or more)i |
88 |
88 |
91 |
90 |
90 |
92 |
91 |
93 |
93 |
91 |
87 |
85 |
90 |
90 |
90 |
91 |
91 |
93 |
92 |
90 |
89 |
90 |
92 |
91 |
90 |
93 |
89 |
93 |
94 |
91 |
| Hib (3 doses or more)j |
89 |
90 |
92 |
92 |
91 |
93 |
92 |
93 |
93 |
94 |
87 |
89 |
92 |
91 |
88 |
91 |
93 |
92 |
92 |
94 |
90 |
92 |
94 |
95 |
93 |
94 |
92 |
95 |
94 |
94 |
| Hepatitis B (3 doses or more)k |
81 |
81 |
86 |
87 |
88 |
90 |
90 |
91 |
92 |
93 |
80 |
79 |
83 |
87 |
87 |
88 |
89 |
91 |
91 |
92 |
81 |
84 |
88 |
89 |
90 |
91 |
89 |
93 |
93 |
93 |
| Varicellal |
8 |
22 |
47 |
61 |
70 |
80 |
82 |
86 |
89 |
89 |
6 |
18 |
44 |
59 |
70 |
81 |
82 |
88 |
88 |
88 |
11 |
25 |
49 |
62 |
70 |
82 |
81 |
85 |
89 |
89 |
| 3 PCVm |
— |
— |
— |
— |
— |
— |
37 |
66 |
70 |
84 |
— |
— |
— |
— |
— |
— |
35 |
65 |
71 |
80 |
— |
— |
— |
— |
— |
— |
38 |
67 |
71 |
86 |
| — Not available. |
| a Based on family income and household size using US Bureau of Census poverty thresholds for 2001. |
| b From 1996 to 2000, the 1977 OMB Standards for Data on Race and Ethnicity were used. From 2002 onward, the 1997 OMB Standards for Data on Race and Ethnicity were used. |
| c Persons of Hispanic origin may be of any race. |
| d The 4:3:1:3:3 series consists of 4 (or more) doses of diphtheria, tetanus toxoids and pertussis vaccines, diphtheria and tetanus toxoids, and diphtheria, tetanus toxoids and any acellular pertussis vaccine (DTP/DT/DTaP); 3 (or more) doses of poliovirus vaccine; 1 (or more) doses of any measles-containing vaccine; 3 (or more) doses of Haemophilus influenzae type b (Hib) vaccine; and 3 (or more) doses of hepatitis B vaccine. |
| e The 4:3:1:3 series consists of 4 (or more) doses of diphtheria, tetanus toxoids and pertussis vaccines, diphtheria and tetanus toxoids, and diphtheria, tetanus toxoids and any acellular pertussis vaccine (DTP/DT/DTaP); 3 (or more) doses of poliovirus vaccine; 1 (or more) doses of any measles-containing vaccine; and 3 (or more) doses of Haemophilus influenzae type b (Hib) vaccine. |
| f The 4:3:1 series consists of 4 (or more) doses of diphtheria, tetanus toxoids and pertussis vaccines, diphtheria and tetanus toxoids, and diphtheria, tetanus toxoids and any acellular pertussis vaccine (DTP/DT/DTaP); 3 (or more) doses of poliovirus vaccine; and 1 (or more) doses of any measles-containing vaccine. |
| g Diphtheria, tetanus toxoids, and pertussis vaccine (4 or more doses of any diphtheria, tetanus toxoids, and pertussis vaccines, including diphtheria and tetanus toxoids and any acellular pertussis vaccine). |
| h Poliovirus vaccine (3 or more doses). |
| i Measles-mumps-rubella (MMR) vaccine (1 or more doses) was used beginning in 2005. The previous coverage years reported measles-containing vaccines (MCV). |
| j Haemophilus influenzae type b (Hib) vaccine (3 or more doses). |
| k Hepatitis B vaccine (3 or more doses). |
| l Varicella vaccine (1 or more doses) is recommended at any visit at or after age 12 months for susceptible children (i.e., those who lack a reliable history of chickenpox.) |
| m The heptavalent pneumococcal conjugate vaccine (PCV) is recommended for all children ages 2–23 months and for certain children ages 24–59 months. The series consists of doses at ages 2, 4 and 6 months, and a booster dose at ages 12–15 months. |
| SOURCE: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics, National Immunization Survey. |